Pharmaron Beijing: Announcement Regarding the Results of Stock Repurchasing and Changes in Shareholding
Pharmaron Beijing: 2024 Interim Performance Forecast
Pharmaron Beijing: Announcement on the Pledge and Release of Pledged Shares by the Actual Controller and its Concerted Action Person of the Company.
Pharmaron Beijing: Announcement regarding redemption of $300 million zero-coupon convertible bonds due in 2026 and withdrawal of their listing status.
Pharmaron Beijing: Announcement listed in Hong Kong
Pharmaron Beijing: Announcement listed in Hong Kong
Pharmaron Beijing: Announcement regarding the progress of repurchasing company shares.
Pharmaron Beijing: Announcement on the supplementary pledge of shares by the concerted action person of the actual controller of the company.
Pharmaron Beijing: Announcement listed in Hong Kong
Pharmaron Beijing: Announcement listed in Hong Kong
Pharmaron Beijing: Announcement on the supplementary pledge of shares by the concerted action person of the actual controller of the company.
Pharmaron Beijing: Progress Announcement on Selling Equity of Overseas Joint Venture Company
Pharmaron Beijing: Announcement regarding the pledge and release of pledged shares by the concerted action persons who are actual controllers of the company.
Pharmaron Beijing: Announcement regarding the redemption of $300 million zero-coupon convertible bonds due in 2026.
Pharmaron Beijing: Announcement of Annual Equity Distribution Implementation in 2023
Pharmaron Beijing: Announcement regarding the redemption of RMB 1916 million zero-coupon USD settlement convertible bonds due in 2026 and the withdrawal of its listing status.
Pharmaron Beijing: Announcement regarding adjustment of the repurchase share price limit after the implementation of the 2023 annual equity distribution.
Pharmaron Beijing: Announcement regarding the pledge and release of pledged shares by the concerted action persons who are actual controllers of the company.
Pharmaron Beijing: Pharmaron (Peking) New Drug Technology Co., Ltd. Articles of Association
Pharmaron Beijing: Announcement of Resolutions for the 2023 Annual Shareholders' Meeting, the 2024 First Category A-Share Shareholders' Meeting, and the 2024 First Category H-Share Shareholders' Meeting.
No Data